![clinicians-view-patient-data-on-tablet.download clinicians-view-patient-data-on-tablet.download](https://cuanschutz.edu/images/librariesprovider109/articles/clinicians-view-patient-data-on-tablet-downloadfe17ece5302864d9a5bfff0a001ce385.jpg?sfvrsn=313f88b9_0)
Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection
Dec 22, 2020Royal Philips , a global leader in health technology, and BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.